Description
Tesamorelin is a stabilised GHRH analogue with a longer half-life than CJC-1295 (no DAC), used where a study needs sustained rather than pulsed receptor activity.
Research context
- Visceral adipose tissue models
- Growth-hormone-axis research
- Longer-exposure comparisons against short-acting GHRH analogues
Handling and storage
Refrigerate the lyophilized vial on arrival; keep reconstituted material cold and use within a short window.
Common questions
How does Tesamorelin differ from CJC-1295?
It is stabilised against rapid breakdown, so receptor exposure lasts longer – the opposite design goal to the short-acting no-DAC version.
Supplied for laboratory research use only. Not for human or veterinary use.
Reviews
There are no reviews yet.